Skip to main navigation
Skip to search
Skip to main content
University of Southern Denmark Home
Help & FAQ
Dansk
English
Home
Researchers
Research Units
Research output
Activities
Projects
Press / Media
Prizes
Teaching
Impacts
Datasets
Search by expertise, name or affiliation
Helge Thisgaard CV
View Scopus Profile
Helge Thisgaard
Department of Clinical Research
Associate Professor
,
KI, OUH, Research unit of Clinical Physiology and Nuclear Medicine (Odense)
https://orcid.org/0000-0001-9492-448X
Email
helge.thisgaard
rsyd
dk
Overview
Fingerprint
Network
Research output
(64)
Activities
(60)
Press / Media
(12)
Similar Profiles
(6)
If you made any changes in Pure these will be visible here soon.
Fingerprint
Fingerprints are formed from scientific publications and create an index of weighted keyword concepts for each individual researcher.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
1,4,7-triazacyclononane-N,N',N''-triacetic acid
100%
Cobalt
66%
Bombesin Receptors
61%
Electrons
59%
Cobalt-55
59%
Glioblastoma
53%
Neoplasms
49%
Radioisotopes
47%
Prostatic Neoplasms
45%
Bombesin
36%
Gallium-68
31%
64Cu-DOTATATE
31%
1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane
29%
dotatate gallium ga-68
29%
Positron-Emission Tomography
28%
Somatostatin Receptors
28%
Prostate-Specific Antigen
27%
oleylamine
27%
Heterografts
26%
AGRO 100
24%
Copper-64
24%
Geologic Sediments
22%
pleiotrophin
21%
Ligands
21%
Isotopes
20%
nucleolin
20%
Cyclotrons
20%
Molecular Imaging
20%
Octreotide
19%
Convection
19%
Temozolomide
19%
Chelating Agents
18%
Positron Emission Tomography Computed Tomography
18%
Computer-Assisted Image Processing
18%
Glu-NH-CO-NH-Lys-(Ahx)-((68)Ga(HBED-CC))
18%
Neuroendocrine Tumors
18%
Deoxyuridine
18%
Neoplastic Stem Cells
18%
Porphyrins
17%
Cell Self Renewal
17%
Membranes
16%
somatostatin receptor 2
16%
Pets
15%
Zinc-68
15%
Therapeutic Uses
15%
Nanoparticles
15%
Methotrexate
14%
Tumor Burden
14%
Fluorodeoxyglucose F18
14%
Somatostatin
14%
Physics & Astronomy
tumors
50%
cancer
41%
radioactive isotopes
38%
therapy
32%
evaluation
25%
cyclotrons
25%
emitters
22%
peptides
18%
glutamates
18%
antigens
17%
ureas
16%
releasing
16%
ligands
13%
radiation therapy
13%
cobalt
12%
positrons
12%
angular momentum
11%
gallium
11%
tomography
10%
mice
10%
membranes
9%
preparation
9%
synthesis
9%
copper
9%
vibration
8%
nuclei
8%
purity
8%
liver
8%
purification
8%
electrons
7%
energy
7%
excitation
6%
delivery
6%
high current
6%
deoxyribonucleic acid
6%
citrates
5%
serums
5%
interactions
5%
computer aided design
5%
Chemical Compounds
Radioisotope
23%
Gastrin-Releasing Peptide
21%
Positron
17%
Radionuclides
17%
Transmetalation
16%
Radioligand
15%
Agent Interacting With Transmitter, Hormone or Drug Receptor
15%
Purification
13%
Purity
13%
Nanoparticle
13%
Encapsulation
11%
Antigen
11%
Dose
10%
Somatostatin
9%
Isotope
8%
Peptide
7%
Reaction Yield
7%
Ligand
7%
Liquid
6%
Ion
5%
